The Chrysalis Effect advertises itself as a support program or treatment for ME/CFS. Chrysalis Effect practitioners pay to receive training and resources, and then offer a Chrysalis Effect program to others.
Evidence[edit | edit source]
No peer-reviewed clinical trial research has been published to show the effectiveness or safety of the Chrysalis Effect.
We urge you to view with extreme caution any approach which claims to offer a cure and/or significant improvement, has not been adequately researched and published with peer-review, and requires the payment of large sums of money.— Action for ME
Advertising complaint[edit | edit source]
The UK's Advertising Standards Authority investigated a complaint about the Chrysalis Effect in 2014, and ruled that the current advertising must not make such claims again.
Learn more[edit | edit source]
- The Chrysalis Effect ruling - Advertising Standards Authority
- Complementary and alternative approaches - Action for ME
See also[edit | edit source]
References[edit | edit source]
myalgic encephalomyelitis (ME) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.